Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial

Ho‐Young Yhim(Jeonbuk National University Hospital), Deok‐Hwan Yang(Chonnam National University Hwasun Hospital), Seung Ju Kim(University of Nebraska–Lincoln), Jinny Park(Gachon University Gil Medical Center), Woo Seob Kim(Samsung Medical Center), T. Kim(Chonnam National University), Jin Sung Kim(Yonsei University), Ho‐Jin Shin(Pusan National University Hospital), G.S. Park(The Catholic University of Korea Seoul St. Mary's Hospital), Youngil Koh(Seoul National University Hospital), Joon Ho Moon(Kyungpook National University Hospital)
Annals of Oncology
December 25, 2020
10.1016/j.annonc.2020.12.009
Cited by 27

Related Papers

Matrix elasticity of void-forming hydrogels controls transplanted-stem-cell-mediated bone formation
|Nature Materials|2015|513
Emission color variation of M2SiO4:Eu2+ (M=Ba, Sr, Ca) phosphors for light-emitting diode
|Solid State Communications|2004|224
Radiation Exposure to the Surgeon During Percutaneous Endoscopic Lumbar Discectomy
|Spine|2012|163
Bojungikki-Tang for Cancer-Related Fatigue: A Pilot Randomized Clinical Trial
|Integrative Cancer Therapies|2010|161
Nonvolatile Ferroelectric Memory Circuit Using Black Phosphorus Nanosheet-Based Field-Effect Transistors with P(VDF-TrFE) Polymer
|ACS Nano|2015|159